TScan Therapeutics, Inc. Common Stock (TCRX)

Typically moves ±7.87% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-12 APPROXIMATE

Across 20 earnings reports since Aug 19, 2021, TScan Therapeutics, Inc. Common Stock (TCRX) has a clear post-earnings pattern. It moves ±7.87% on average after reporting and finishes higher 50.0% of the time. Its largest post-earnings gain was +43.79% (May 10, 2023) and its largest decline was -49.36% (Mar 08, 2023). The next earnings report is predicted for 2026-11-12 (approximate).

Earnings reactions

How TCRX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±7.87%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 12, 2026	☀ PRE	-0.4%	open_in_new
May 06, 2026	☀ PRE	+2.88%	open_in_new
Mar 04, 2026	☀ PRE	+5.31%	open_in_new
Nov 12, 2025	☀ PRE	+0.83%	open_in_new
Aug 12, 2025	☀ PRE	+3.42%	open_in_new
May 06, 2025	☀ PRE	-9.03%	open_in_new
Mar 05, 2025	☀ PRE	-4.7%	open_in_new
Nov 12, 2024	☀ PRE	-5.26%	open_in_new
Aug 12, 2024	☀ PRE	+1.18%	open_in_new
May 13, 2024	☀ PRE	+1.65%	open_in_new
Mar 06, 2024	☀ PRE	+1.42%	open_in_new
Nov 09, 2023	☀ PRE	-2.49%	open_in_new
Aug 10, 2023	☀ PRE	-3.79%	open_in_new
May 10, 2023	☀ PRE	+43.79%	open_in_new
Mar 08, 2023	☀ PRE	-49.36%	open_in_new
Nov 09, 2022	☀ PRE	-0.39%	open_in_new
Aug 10, 2022	☀ PRE	-1.22%	open_in_new
May 09, 2022	☀ PRE	+0.58%	open_in_new
Mar 09, 2022	☀ PRE	+0.27%	open_in_new
Aug 19, 2021	☀ PRE	-19.48%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±7.87%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 13 →

Funds holding

$1866461

Total value held

Buying

10 added · 2 reduced

Blackrock, Inc.

$974860 -45.97%

State Street Corp

$203187 Held

Morgan Stanley

$193952 +13.96%

Northern Trust Corp

$136016 +42.41%

Goldman Sachs Group Inc

$69111 +89.21%

SEC Filing Types

description SCHEDULE 13G/A

3 chevron_right

description 10-Q

1 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
8-K	20260902	open_in_new SEC.gov
8-K	20260818	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
10-Q	20260812	open_in_new SEC.gov
8-K	20260812	open_in_new SEC.gov
8-K	20260622	open_in_new SEC.gov
4	20260522	open_in_new SEC.gov
4	20260522	open_in_new SEC.gov
4	20260522	open_in_new SEC.gov

Frequently asked about TCRX earnings

When does TScan Therapeutics, Inc. Common Stock report earnings next? expand_more

TScan Therapeutics, Inc. Common Stock (TCRX)'s next earnings date is approximate for 2026-11-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does TCRX stock move after earnings? expand_more

Over 20 reports, TCRX has moved an average of ±7.87% the session after earnings, closing higher 50.0% of the time.

What was TCRX's biggest post-earnings move? expand_more

TCRX's largest post-earnings gain on record was +43.79% on May 10, 2023, and its largest decline was -49.36% on Mar 08, 2023.

Where can I find TScan Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of TScan Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.